Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Auditor Change
confidence 95%
filed 2026-06-08
Item 4.01 discloses that AOGB CPA Limited resigned as the independent registered public accounting firm of Society Pass Incorporated effective immediately on June 2, 2026. The filing explicitly states AOGB did not issue an audit opinion on the 2025 financial statements and confirms no disagreements or reportable events occurred. This is a clear auditor change event that would materially affect investor assessment of the company's financial reporting reliability.
View raw filing on EDGAR →
8-K
Auditor Change
confidence 98%
filed 2026-06-08
The filing discloses under Item 4.01 that Assure CPA, LLC resigned as the Company's independent registered public accounting firm on June 3, 2026, following its merger into Sadler Gibb & Associates, LLC, and that Sadler Gibb was engaged as the new auditor on June 5, 2026. The filing explicitly states there were no disagreements or reportable events with the prior auditor, indicating a routine transition rather than a dispute-driven change. This is a classic auditor change event material to investors' assessment of financial reporting oversight.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-08
The filing discloses entry into an underwriting agreement for a firm commitment underwritten offering of 592,270 shares of common stock and 292,135 warrants at $18.00 per unit, generating approximately $5.3 million in gross proceeds (or $6.1 million if the overallotment option is exercised). This is a material dilutive equity issuance under Item 1.01, with detailed warrant terms including exercise prices and reset provisions. The offering is expected to close June 9, 2026, and proceeds will fund development of NCT business, R&D, and general corporate purposes.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-06-08
The filing discloses an unregistered private placement of convertible notes ($500,000 principal at the June 3, 2026 closing, with up to $3,000,000 authorized) and warrants to purchase common stock, made in reliance on Section 4(a)(2) and Regulation D Rule 506(b). The convertible notes convert into common stock at $1.60 per share, and warrants are exercisable at $1.75 per share, creating significant dilution. Item 3.02 explicitly confirms the unregistered sale of equity securities in a private placement.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-06-08
Item 1.01
Celcuity entered into an underwriting agreement on June 3, 2026, to issue $575 million aggregate principal amount of 0.250% Convertible Senior Notes due 2032 (including full exercise of a $75 million over-allotment option), convertible into common stock at an initial conversion price of approximately $124.53 per share. The offering raised approximately $557 million in net proceeds and creates substantial dilution potential for existing shareholders.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-08
Item 1.02
Celcuity completed a voluntary prepayment of approximately $137.5 million to fully satisfy and discharge its Amended and Restated Loan and Security Agreement with Oxford Finance and Innovatus Life Sciences, terminating all obligations under the facility and eliminating associated debt covenants.
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-06-08
Item 2.03
Item 2.03 incorporates Item 1.01 by reference, disclosing a material transaction that creates direct financial obligations consistent with M&A activity or a significant change of control event.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-08
The filing discloses a 1-for-5 reverse stock split effectuated via Certificate of Change filed June 2, 2026, becoming effective June 11, 2026. While reverse stock splits are structural corporate actions, this one is material to investors as it reduces outstanding shares from ~365 million to ~73 million and affects trading mechanics, stock option/RSU adjustments, and fractional share treatment. The event does not fit neatly into the specific taxonomy categories (not a bylaw amendment alone, not M&A, not an impairment), making "other_material" the most appropriate classification for this significant capital structure modification.
View raw filing on EDGAR →
8-K
Auditor Change
confidence 95%
filed 2026-06-08
Item 4.01
AOGB CPA Limited resigned as the Company's independent registered public accounting firm effective June 2, 2026, and was replaced by Barton CPA PLLC on June 4, 2026. This is a clear auditor change under Item 4.01. The filing discloses no disagreements or reportable events, suggesting a routine transition rather than a crisis-driven change, but the change itself is material as it affects the registrant's financial reporting oversight and audit continuity.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-06-08
The filing discloses Item 2.02 (Results of Operations and Financial Condition) with a press release dated June 8, 2026 reporting financial results for the first quarter ended April 30, 2026. This is a standard earnings release disclosure, material to investors as it provides quarterly financial performance information.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-08
The filing discloses the appointment of Andriy Mushak as fractional Chief Financial Officer effective June 6, 2026, following the departure of Alan Weichselbaum. While both a departure and appointment occur, the principal disclosed action centers on the appointment of a new CFO with detailed background information and compensation terms ($6,000/month via consulting agreement with LMAM Consulting Group). This is material as CFO changes affect investor assessment of financial reporting and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-08
The filing discloses the appointment of Andriy Mushak as fractional Chief Financial Officer effective June 6, 2026, following the departure of Alan Weichselbaum. While both a departure and appointment occur, the principal disclosed action centers on the appointment of a new CFO with detailed background information and compensation terms ($6,000/month). This is material as CFO changes affect investor assessment of financial reporting and governance.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-06-08
Hongyu Zhou, Chairman of the Board of AiRWA Inc., resigned from the Board effective immediately on June 2, 2026. This is a clear executive departure of a senior officer (board chair). The filing explicitly states the resignation was not due to disagreement with the company, but the departure of a chairman is material to investors' assessment of corporate governance and leadership continuity.
View raw filing on EDGAR →
8-K
Restatement
confidence 98%
filed 2026-06-08
The filing discloses non-reliance on previously issued financial statements spanning fiscal years 2024–2025 and multiple quarterly periods (Q1–Q3 2025, Q1 2026). The Board concluded on June 3, 2026 that audited and unaudited financial statements should no longer be relied upon due to material errors including misclassification of $7.1M in client funds, an $8.2M subscription receivable reclassification to contra-equity, intercompany elimination errors, and foreign currency translation adjustments. This is a classic Item 4.02 restatement disclosure with substantial corrections to assets, equity, and net income across multiple periods.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-06-08
This 8-K discloses the completion of Aeon Acquisition I Corp.'s initial public offering (IPO) on June 4, 2026, with 12.5 million units sold at $10.00 per unit generating $125 million in gross proceeds, plus an additional $18.75 million from full exercise of the underwriters' over-allotment option. While technically an IPO rather than a traditional M&A transaction, the filing is structured around Item 1.01 (Entry into Material Definitive Agreements) and Item 3.02 (Unregistered Sales of Equity Securities), and the IPO represents a material capital-raising event that fundamentally changes the company's structure and capitalization. The company is a special purpose acquisition company (SPAC) formed to pursue an initial business combination, making this IPO disclosure material to investors.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-08
Item 5.07 discloses the results of BTCS Inc.'s 2026 Annual Meeting of Shareholders held on June 8, 2026, including voting outcomes for director elections (Charles Allen, Charles Lee, Ashley DeSimone), auditor ratification (Forvis Mazars, LLP), and three equity plan amendments. All proposals passed, with director elections requiring plurality votes and other matters requiring majority approval. This is a material shareholder vote result disclosure as required by Item 5.07.
View raw filing on EDGAR →
8-K
Auditor Change
confidence 95%
filed 2026-06-08
The filing discloses under Item 4.01 that Assure CPA, LLC resigned as the Company's independent registered public accounting firm on June 3, 2026, following its merger into Sadler Gibb & Associates, LLC, and that Sadler Gibb was engaged as the new auditor on June 8, 2026. This is a clear auditor change event. The materiality is heightened by the fact that the prior auditor's reports contained an explanatory paragraph expressing substantial doubt about the Company's ability to continue as a going concern.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-06-08
Item 5.01
Guangzhe Su disposed of his controlling block of shares (from 52.06% to less than 0.01%) and resigned from all officer and director positions, resulting in a change of control of the registrant. Shares were transferred to multiple new holders including Yan Li (10%), Yang Liu (10%), and others, fundamentally altering the company's ownership and control structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-06-08
Item 5.02
Xiangying Meng was appointed as Chairman and CEO (promoted from CFO) effective June 5, 2026, and two new directors (Yang Liu and Yong Yang) were appointed, following the resignation of Chairman/CEO Guangzhe Su and three directors as part of the change in control.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-08
Item 5.03
The company changed its corporate name from Brilliant N.E.V. Corp. to Origin Tea Inc. and implemented a 1-for-8 reverse stock split, both approved by the Board and stockholders and filed with the Nevada Secretary of State on June 7, 2026. The reverse stock split proportionately reduces authorized shares from 345 million to 43.125 million and materially affects share count and trading mechanics.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-08
Item 8.01
The Board approved a material strategic pivot to the tea industry, including incorporation of foreign subsidiaries (Origin Tea Industry Limited in Hong Kong and a wholly foreign-owned enterprise in China), relocation of principal executive offices to Hainan, and authorization of a private placement financing program. The company remains a shell company with no securities yet issued under the financing program.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This is a clear disclosure of shareholder vote results from MariMed Inc.'s June 4, 2026 Annual Meeting of Stockholders. The filing reports the specific vote tallies for two proposals: election of four directors (Jon R. Levine, Edward Gildea, David Allen, and Eva Selhub, M.D.) and advisory approval of M&K CPAs PLLC as independent auditors for fiscal 2026. The detailed vote counts (FOR, WITHHELD, BROKER NON-VOTE for directors; FOR, AGAINST, ABSTAIN for auditors) are the core disclosure required under Item 5.07.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-08
Item 8.01
The disclosure concerns the conversion price of subordinated convertible notes due 2031, which affects the terms and potential dilution of an outstanding debt instrument. While the specific content is not provided, conversion price adjustments or resets on convertible securities are material to investors assessing capital structure and dilution risk, but do not fit neatly into the more specific event categories (not a new issuance under dilutive_issuance, not a covenant breach, and not exec/M&A activity). This is classified as other_material given its disclosure under Item 8.01 and relevance to the company's financial obligations.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-06-08
Item 5.02
Stockholders approved the Smart Sand, Inc. 2026 Equity Incentive Plan and 2026 Employee Stock Purchase Plan on June 2, 2026, authorizing 2,400,000 new shares under the equity plan and 3,000,000 shares for the ESPP, along with forms of award agreements for restricted stock awards.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
Smart Sand held its Annual Meeting on June 2, 2026, with stockholders voting on five proposals: election of two Class I directors (Sharon Spurlin and Timothy J. Pawlenty), ratification of Grant Thornton LLP as auditor, advisory approval of named executive officer compensation, approval of the 2026 Equity Incentive Plan, and approval of the 2026 Employee Stock Purchase Plan.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
Avalo Therapeutics held its Annual Meeting of Stockholders on June 2, 2026, with voting results on three proposals: election of seven board directors, approval of the amended and restated 2016 ESPP, and ratification of Ernst & Young LLP as independent auditor.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-08
Item 1.01
Nurix entered into a material License and Collaboration Agreement with Roche involving an exclusive worldwide license to develop and commercialize bexobrutideg. The transaction includes a $700 million upfront payment and up to $2.3 billion in total potential payments, with Nurix retaining co-development and co-commercialization rights in the U.S. and receiving royalties on ex-U.S. sales.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This is a clear disclosure of shareholder voting results from SAIC's Annual Meeting of Stockholders held on June 3, 2026, covering five distinct matters: election of ten directors, say-on-pay advisory vote, say-on-pay frequency vote, 2023 Equity Incentive Plan share authorization increase, and auditor ratification. The filing presents final vote tallies for each proposal, which is the core content required by Item 5.07.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 90%
filed 2026-06-08
Item 5.02
Rajiv Basu was appointed as a director and Audit Committee Chair of James River Group Holdings, Inc., effective June 8, 2026. Concurrently, director Dennis J. Langwell resigned effective June 16, 2026. The appointment of Basu to the board and Audit Committee chair position represents a material change to the company's governance structure.
View raw filing on EDGAR →
8-K
Bankruptcy Filing
confidence 99%
filed 2026-06-08
Item 1.03
GoHealth, Inc. and its subsidiaries filed voluntary petitions under Chapter 11 of the Bankruptcy Code on June 7, 2026, in the U.S. Bankruptcy Court for the District of Delaware, with the company operating as debtors-in-possession under a prepackaged chapter 11 plan of reorganization.
View raw filing on EDGAR →
8-K
Covenant Breach
confidence 75%
filed 2026-06-08
Item 2.04
The Chapter 11 bankruptcy filing constitutes an event of default under two material debt agreements (Superpriority Senior Secured Credit Agreement and Credit Agreement), causing principal and accrued interest to become immediately due and payable.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 75%
filed 2026-06-08
Item 5.02
CEO Vijay Kotte entered into a Cash Performance Plan Award Agreement establishing a multi-tranche cash performance award with specified measurement dates and performance goals, including an initial payment of approximately $2.87 million already earned, with vesting conditions and forfeiture provisions.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-08
Item 8.01
Strive announced a bitcoin purchase of 32 BTC at ~$63,911 per coin during June 2-7, 2026, along with updates to its treasury holdings (cash, bitcoin, and STRC Stock positions) and share counts. While this reflects the company's ongoing bitcoin treasury strategy, the disclosure does not fit neatly into standard 8-K event categories. The purchase and treasury updates are material to investors assessing the company's asset composition and capital allocation, but the event is primarily an operational/treasury update rather than a discrete corporate action (M&A, impairment, covenant breach, etc.). Classified as other_material because it is a material treasury/asset activity that does not align with more specific event types.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-06-08
Item 5.02
Three directors—Eric S. Rosenfeld, David D. Sgro, and Anthony Laura—were removed from the Board of Directors on June 7, 2026, pursuant to the Company's Bye-Laws provision 24.1.7. The removal of three board members simultaneously represents a material change in the composition of the Company's governance structure and would affect a reasonable investor's assessment of the registrant's leadership and strategic direction.
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-06-08
Item 1.01
Construction Partners entered into a Sixth Amendment to its credit agreement on June 3, 2026, increasing the revolving credit facility from $500 million to $700 million and adjusting financial covenants. The amendment includes Limited Condition Transaction provisions for acquisition financing, providing additional flexibility for capital access and strategic M&A activity.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This Item 5.07 disclosure reports the final voting results from Intuitive Machines' Annual Meeting of Stockholders held on June 4, 2026. The filing presents tabulated results for two proposals: election of Class III directors (Dr. Kamal Ghaffarian and Stephen Altemus) and ratification of Grant Thornton LLP as independent auditor. Both proposals passed with substantial majorities, and the disclosure is material as it confirms the composition of the board and auditor for the fiscal year.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This is a clear disclosure of shareholder vote results from Prime Medicine's June 5, 2026 annual meeting of stockholders. The filing reports voting outcomes for two proposals: (i) election of Michael Kelly and David Schenkein, M.D. as Class I Directors, and (ii) ratification of PricewaterhouseCoopers LLP as independent auditor. The detailed vote tallies (For, Against, Withheld, Abstentions, Broker Non-Votes) are presented in tabular form, which is the standard format for Item 5.07 disclosures. Director elections and auditor ratification are material governance matters affecting investor assessment of board composition and audit oversight.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-08
Item 2.02
Oil-Dri Corp of America issued a press release announcing financial results for the third quarter ended April 30, 2026.
View raw filing on EDGAR →
8-K
Material Litigation
confidence 92%
filed 2026-06-08
Item 8.01
The disclosure reports a final arbitration award (June 2, 2026) involving a reinsurance agreement dispute between Kestrel's subsidiary Maiden Reinsurance and a cedant. The arbitration panel found an intentional and material breach by the cedant, awarded $1.0 million in attorneys' fees to the registrant, and mandated substantial adjustments to billing, reserves, and security—including potential repayment of approximately $10.8 million previously paid. The registrant explicitly states it is "evaluating the effect of the Final Award" with uncertain financial statement impacts, signaling material consequences to the company's financial position and obligations under the reinsurance agreement.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of FIGS' 2026 annual meeting of stockholders held on June 3, 2026. The filing presents voting results for three proposals: election of three Class II directors (Heather Hasson, Kenneth Lin, and Melanie Whelan), ratification of Ernst & Young LLP as independent auditor, and advisory approval of named executive officer compensation. All three proposals passed. This is a material disclosure as shareholder votes on director elections and auditor ratification directly affect corporate governance and investor confidence.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
Ameresco held its 2026 Annual Meeting of Stockholders with four proposals voted on: election of two class I directors (Claire Hughes Johnson and Frank V. Wisneski), ratification of RSM US LLP as independent auditor, approval of a 3.2 million share increase to the 2020 Stock Incentive Plan, and an advisory vote on named executive officer compensation. All proposals passed with substantial majorities.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
This Item 5.07 filing discloses the final voting results from 10x Genomics' annual meeting of stockholders held on June 4, 2026, covering three proposals: election of three Class I directors (Serge Saxonov, Benjamin J. Hindson, and John R. Stuelpnagel), ratification of Ernst & Young LLP as independent auditor, and advisory approval of named executive officer compensation. The disclosure includes vote tallies (votes for, against, abstentions, and broker non-votes) for each proposal, which is the core content of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-08
Item 8.01
The disclosure announces a monthly common dividend of $0.08 per share declared by the Board of Trustees, payable July 31, 2026. While dividend declarations are routine for REITs and BDCs like Ellington Credit, this is material to investors as it affects shareholder returns and capital allocation. However, it does not fit neatly into the more specific event categories (not earnings, not executive action, not M&A, etc.), warranting classification as other_material.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-08
Item 5.07
This Item 5.07 filing discloses the final voting results from MarketWise's June 4, 2026 Annual Meeting of Stockholders on four proposals: election of directors (Matthew Turner), a say-on-pay advisory vote (which failed to pass), a say-on-frequency proposal (approved for one-year intervals), and ratification of Grant Thornton LLP as independent auditor. The failure of the say-on-pay proposal is material to investors as it signals stockholder dissatisfaction with executive compensation, warranting disclosure of the specific vote tallies.
View raw filing on EDGAR →
8-K
Bankruptcy Filing
confidence 95%
filed 2026-06-08
Item 1.01
Inotiv and its subsidiaries filed voluntary petitions under Chapter 11 of the Bankruptcy Code on June 3, 2026. The company entered into a debtor-in-possession financing facility on June 5, 2026 to fund operations during the reorganization proceedings.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 95%
filed 2026-06-08
Item 3.01
Nasdaq notified Inotiv on June 4, 2026 that its common shares will be delisted effective June 11, 2026, as a direct result of the company's Chapter 11 bankruptcy filing. The company does not intend to appeal the delisting determination.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-08
Item 5.02
Bobby Lavan was promoted to President of Lucky Strike Entertainment Corp effective June 8, 2026, in addition to his existing CFO role, with compensatory adjustments including a salary increase to $850,000 and LTIP target of $1,500,000.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-08
Item 7.01
This Item 7.01 disclosure is a business update providing portfolio performance metrics, capital inflows, and liquidity position for TPG Twin Brook Capital Income Fund. While it includes material operational information (9.8% annualized returns since inception, $4.5 billion portfolio, $181 million capital inflows, $832 million liquidity), it does not fit neatly into the specific event categories. The disclosure is a periodic business update rather than a discrete material event like M&A, executive changes, restatement, or covenant breach. It is material to investors assessing fund performance and financial health, but lacks the triggering event character of the more specific categories.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-08
Item 5.07
WillScot Holdings held its Annual Meeting of stockholders and voted on five proposals: election of nine directors, ratification of Ernst & Young LLP as independent auditor, advisory approval of named executive officer compensation, frequency of future advisory votes on compensation, and approval of the 2026 Incentive Award Plan. All proposals passed with substantial majorities.
View raw filing on EDGAR →
8-K
Auditor Change
confidence 98%
filed 2026-06-08
Item 4.01
This is a clear auditor change disclosure under Item 4.01. Assure CPA, LLC resigned as the independent registered public accounting firm on June 3, 2026 due to its merger into Sadler, Gibb & Associates, LLC, which was simultaneously engaged as the new auditor on June 5, 2026. The filing explicitly states there were no disagreements or reportable events, indicating a routine transition rather than a dispute-driven change. Auditor changes are material events affecting investor assessment of financial reporting reliability.
View raw filing on EDGAR →